Peel Therapeutics

📍 Salt Lake City, United States👥 12 employees💰 Last funded Mar 2026
Biotechnology Research🌐 peeltx.com
Website LinkedIn
Over the course of millions of years, nature evolved to create the world’s most awe-inspiring, life-changing health outcomes. Peel Therapeutics translates these evolutionary outliers to develop medicines for patients with cancer and inflammatory diseases. Using scientific and medical expertise, state-of-the-art technology and drug development knowledge, we redesign what nature offers into medicines for patients by tackling solubility, scalability, and bioavailability. Our clinical stage therapeutic pipeline treats a spectrum of devastating conditions, with a near-term focus on cancer and inflammation. At Peel Therapeutics, we push the limits of biology to develop highly effective and safe medicines for patients that transcend the incremental.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Peel Therapeutics?
Peel Therapeutics has 1 investor on record on gritt.io.
When did Peel Therapeutics last raise funding?
The most recent investment in Peel Therapeutics recorded on gritt.io was in March 2026.
What industry is Peel Therapeutics in?
Peel Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Peel Therapeutics based?
Peel Therapeutics is headquartered in Salt Lake City, United States.